well thats about as bare bones an announcement as you get. To any new shareholders scratching their head, this is referring to the report of successful canine phase 2 trials that have now been presented to Elanco or "Vet Major" as they are recently called by management. Having presened the report, Elanco will now have the opportunity to choose to enter an option agreement with PAA to take MPL into further trials and commercialization.
Ann: Final Report delivered under Option Agreement, page-4
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.90M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 44819 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 25000 | 1 |
View Market Depth
| Last trade - 16.12pm 07/05/2024 (20 minute delay) ? |
| PAA (ASX) Chart |
Day chart unavailable